Home / Health / UK Offers MenB Shots to 1 Million Youth
UK Offers MenB Shots to 1 Million Youth
12 Jun
Summary
- Around one million young people are eligible for the MenB vaccine.
- Vaccination program targets 17-18 year olds and university students.
- Two doses of the GSK Bexsero vaccine will be administered.
A crucial Meningitis B vaccination programme is scheduled to commence this summer, targeting around one million young individuals. This one-off campaign, organised by the UK Health Security Agency, will administer two doses of the GSK Bexsero vaccine. Eligibility extends to Year 13 students aged 17 to 18, and individuals under 25 who are transitioning to university or other residential education settings in autumn 2026.
The initiative responds to recent Meningitis B outbreaks, aiming to quickly contain risks among young adults. MenB, a serious bacterial infection, can lead to severe illness, sepsis, and permanent damage if untreated. The vaccine offers protection for six to seven years and is administered via injection, with full protection developing at least two weeks after the second dose.
Eligible Year 13 students, born between 1 September 2007 and 31 August 2008, will be notified through the NHS App, text, or post. Other eligible individuals under 25 can book appointments directly at pharmacies. The first dose is available from 20 July, with the second dose to be given in August, ensuring at least a four-week interval between administrations.
